I did and it doesn't disagree.
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these...journals.plos.org
COVID - 1x10-3
Smallpox - 1x10−6
So again, if COVID is diverging every year, like we saw last December. It's about a thousand years for Smallpox.
Which agrees with historical record.
Smallpox and other viruses plagued humans much earlier than suspected
Genetic research is rewriting the history of diseases.www.nature.com
So with a vaccine, there is plenty of time to eradicate smallpox. Not so much with COVID.
Comparing the two would fall under academic dishonesty if a student omitted relevant mutation rates and passed them off as one and the same to make their point on a topic. You should know that.
I see. So you (a) missed the part about some DNA and RNA viruses mutating at the same rate, and (b) that as mutations are random events then statistically mutations can occur at any point too, just that the chances occur more with RNA viruses and (c) the premise of breaking the chain of infection does break the reservoir of virus and hence aids in slowing mutations and is an obviously valid approach as shown by prior vaccination.
Finally (d) strains of COVID aren’t 100% vaccine resistant, in fact the paper I showed you suggests 88% efficacy against delta from most double doses of vaccine.
The dishonesty is in moving towards a claim where vaccination does very little for the situation we are currently in.